Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Transarterial Chemoembolization (TACE) vs. CyberKnife for Recurrent Hepatocellular Carcinoma (HCC)

This study has been withdrawn prior to enrollment.
Sponsor:
Collaborator:
Stanford University
Information provided by (Responsible Party):
Accuray Incorporated
ClinicalTrials.gov Identifier:
NCT01318200
First received: March 16, 2011
Last updated: February 16, 2012
Last verified: February 2012
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: February 2016
  Estimated Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)